Brown, W., & Coles, A. (2013). Alemtuzumab: Evidence for its potential in relapsing-remitting multiple sclerosis. Drug design, development and therapy, 7, 131-138. https://doi.org/10.2147/DDDT.S32687
Citácia podle Chicago (17th ed.)Brown, William, a Alasdair Coles. "Alemtuzumab: Evidence for Its Potential in Relapsing-remitting Multiple Sclerosis." Drug Design, Development and Therapy 7 (2013): 131-138. https://doi.org/10.2147/DDDT.S32687.
Citácia podľa MLA (8th ed.)Brown, William, a Alasdair Coles. "Alemtuzumab: Evidence for Its Potential in Relapsing-remitting Multiple Sclerosis." Drug Design, Development and Therapy, vol. 7, 2013, pp. 131-138, https://doi.org/10.2147/DDDT.S32687.
Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..